These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 12406098

  • 21. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
    Ruivard M.
    Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
    [Abstract] [Full Text] [Related]

  • 22. [Hereditary hyperferritinaemia-cataract syndrome].
    van der Klooster JM.
    Ned Tijdschr Geneeskd; 2003 Sep 27; 147(39):1923-8. PubMed ID: 14560693
    [Abstract] [Full Text] [Related]

  • 23. Autosomal dominant reticuloendothelial iron overload (HFE type 4) due to a new missense mutation in the FERROPORTIN 1 gene (SLC11A3) in a large French-Canadian family.
    Rivard SR, Lanzara C, Grimard D, Carella M, Simard H, Ficarella R, Simard R, D'Adamo AP, De Braekeleer M, Gasparini P.
    Haematologica; 2003 Jul 27; 88(7):824-6. PubMed ID: 12857562
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Two novel mutations in the L ferritin coding sequence associated with benign hyperferritinaemia unmasked by glycosylated ferritin assay.
    Thurlow V, Vadher B, Bomford A, DeLord C, Kannengiesser C, Beaumont C, Grandchamp B.
    Ann Clin Biochem; 2012 May 27; 49(Pt 3):302-5. PubMed ID: 22535864
    [Abstract] [Full Text] [Related]

  • 27. Role of liver magnetic resonance imaging in hyperferritinaemia and the diagnosis of iron overload.
    Ruefer A, Bapst C, Benz R, Bremerich J, Cantoni N, Infanti L, Samii K, Schmid M, Vallée JP.
    Swiss Med Wkly; 2017 May 27; 147():w14550. PubMed ID: 29120023
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hyperferritinaemia not always a sign of iron overload.
    Loffeld RJ.
    Acta Gastroenterol Belg; 2007 May 27; 70(4):360-2. PubMed ID: 18330093
    [Abstract] [Full Text] [Related]

  • 30. Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing.
    O'Toole R, Romeril K, Bromhead C.
    Intern Med J; 2017 Apr 27; 47(4):447-454. PubMed ID: 28019068
    [Abstract] [Full Text] [Related]

  • 31. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    N Engl J Med; 2005 Apr 28; 352(17):1769-78. PubMed ID: 15858186
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A point mutation in the iron-responsive element of the L-ferritin in a family with hereditary hyperferritinemia cataract syndrome.
    Wong K, Barbin Y, Chakrabarti S, Adams P.
    Can J Gastroenterol; 2005 Apr 28; 19(4):253-5. PubMed ID: 15861269
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.